Medtronic Widens Parkinson’s aDBS Opportunity With Key US Approvals
‘The Largest Commercial Launch Of Brain-Computer Interface Technology Ever’
Medtronic’s US FDA approval for BrainSense aDBS and BrainSense EI software features of the Percept neurostimulator device has quickly followed CE marking in January.
